King Michael - Insider Non-Derivative Transactions at SAB Biotherapeutics, Inc. (SABS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 30, 2023, King Michael's relationship to SAB Biotherapeutics, Inc. (SABS) is Officer (CHIEF FINANCIAL OFFICER), and currently has 5,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SABS insiders.
Data Source: SEC.
King Michael - Insider Non-Derivative Transactions at SABS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 1, 2023 | P -- (Common Stock) | 5000 | 0.9 | 5000 |